My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)

22.93 +1.09 (+4.99%)

Streaming Delayed Price Updated: 1:54 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sarepta Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

33 34 Next >

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an...

Via MarketMinute

How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗

December 02, 2025

Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam.

Via Investor's Business Daily

Sarepta Wins FDA Approval To Begin Study On Reducing Liver Injury Risk With Elevidys ↗

November 25, 2025

The data from the study cohort will be used to determine whether administering sirolimus before and after the ELEVIDYS infusion can help reduce acute liver injury, the company said.

Via Stocktwits

Sarepta Therapeutics Stock Crashes After-Hours On DMD Trial Failure, Q3 Print — Retail Still Sees Long-Term Comeback ↗

November 03, 2025

Via Stocktwits

Sarepta Announces Approval to Begin ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne

November 25, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

Sarepta Provides Progress Update for SRP-1003, its Investigational siRNA treatment for Myotonic Dystrophy Type 1

November 24, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

Tech Edges Up Ahead Of Nvidia's Earnings, Bitcoin Sinks Below $90,000: What's Moving Markets Wednesday? ↗

November 19, 2025

All eyes are on Nvidia Corp. (NASDAQ:NVDA) as the world's most valuable company prepares to report third-quarter earnings after the close, a pivotal moment that could steer

Via Benzinga

Sarepta Stock Slides Premarket After New FDA Warning Shrinks Market For Its $3.2M DMD Gene Therapy ↗

November 17, 2025

FDA added a boxed warning to Elevidys after two pediatric deaths and imposed stricter monitoring rules.

Via Stocktwits

Topics Death

2 Beaten-Down Stocks to Avoid Right Now ↗

November 15, 2025

There might be plenty more downside for these biotechs.

Via The Motley Fool

Topics Death

Sarepta Shares Jump After FDA Approves Updated Elevidys Label ↗

November 14, 2025

Sarepta Therapeutics shares jumped after the FDA issued a new boxed warning for Elevidys.

Via Benzinga

Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information

November 14, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 11, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 05, 2025

Via Benzinga

Analyst Ratings Send Ripples Through Markets: Sarepta's Resilience vs. Pinterest's Plunge

November 05, 2025

The financial markets are a complex ecosystem, constantly reacting to a myriad of inputs, from macroeconomic data to geopolitical shifts. Among the most closely watched catalysts are the pronouncements...

Via MarketMinute

This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

November 05, 2025

Via Benzinga

Sarepta Therapeutics Shares Plummet as Key DMD Treatments Miss Primary Endpoint in Late-Stage Trial

November 04, 2025

Sarepta Therapeutics Inc. (NASDAQ: SRPT) experienced a dramatic downturn in its stock valuation today, November 4, 2025, following the announcement of disappointing results from a pivotal late-stage...

Via MarketMinute

Topics Death

Which stocks are experiencing notable movement on Tuesday? ↗

November 04, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Gold Falls Over 1%; Uber Shares Decline After Q3 Results ↗

November 04, 2025

Via Benzinga

Sarepta Faces Investor Skepticism As Duchenne Data Falls Short Of Statistical Significance ↗

November 04, 2025

Sarepta's Duchenne trial missed its main goal but showed trends favoring treatment; Q3 earnings topped estimates amid Elevidys sales weakness.

Via Benzinga

Tuesday's session: top gainers and losers ↗

November 04, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It ↗

November 04, 2025

Enough though Sarepta shares are crashing, "Pharma Bro" Martin Shkreli says he still likes the stock.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 04, 2025

Via Benzinga

These stocks are gapping in today's session ↗

November 04, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Insperity Posts Downbeat Q3 Results, Joins IAC, Archer-Daniels-Midland And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

November 04, 2025

Via Benzinga

Tuesday's pre-market session: top gainers and losers ↗

November 04, 2025

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 04, 2025

Via Benzinga

Dow Futures Edge Lower On Pullback Fears: PLTR, SRPT, TSLA, AMD Among Stocks To Watch ↗

November 04, 2025

While Dow Jones futures were down by 0.72% at the time of writing, the S&P 500 futures fell 1.02%.

Via Stocktwits

Topics ETFs Stocks

Why Upwork Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗

November 04, 2025

Via Benzinga

Sarepta Therapeutics Stock Is Tumbling After The Close: Here's Why ↗

November 03, 2025

Sarepta shares are plunging in extended trading Monday after the company reports third-quarter results and provided an update on its ESSENCE study.

Via Benzinga

These stocks are moving in today's after hours session ↗

November 03, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.